<!DOCTYPE html><html><head><title>Cancer-related acute pain: a systematic review of evidence-based interventions for Putting Evidence Into Practice.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Guideline Title
</h3>
<div class='FieldValue'>
<div class="content_title">Cancer-related acute pain: a systematic review of evidence-based interventions for Putting Evidence Into Practice.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Bibliographic Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Sundaramurthi T, Gallagher N, Sterling B. Cancer-related acute pain: a systematic review of evidence-based interventions for Putting Evidence Into Practice. Clin J Oncol Nurs. 2017 Jun 1;21(3):13-30. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28524911 " target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Aiello-Laws L, Reynolds J, Deizer N, Peterson M, Ameringer S, Bakitas M. Putting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults. Clin J Oncol Nurs. 2009 Dec;13(6):649-55. [55 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>NEATS Assessment
</h2>
<div class='field field_picklist-one'>
<h3>
Disclosure of Guideline Funding Source
</h3>
<div class='FieldValue'>
No
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Disclosure and Management of Financial Conflict of Interests
</h3>
<div class='FieldValue'>
3
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Guideline Development Group Composition: Multidisciplinary Group
</h3>
<div class='FieldValue'>
Yes
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Guideline Development Group Composition: Methodologist Involvement
</h3>
<div class='FieldValue'>
Yes
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Guideline Development Group Composition: Patient and Public Perspectives
</h3>
<div class='FieldValue'>
1
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Use of a Systematic Review of Evidence: Search Strategy
</h3>
<div class='FieldValue'>
4
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Use of a Systematic Review of Evidence: Study Selection
</h3>
<div class='FieldValue'>
5
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Use of a Systematic Review of Evidence: Synthesis of Evidence
</h3>
<div class='FieldValue'>
5
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Evidence Foundations for and Rating Strength of Recommendations: Grading the Quality or Strength of Evidence
</h3>
<div class='FieldValue'>
3
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Evidence Foundations for and Rating Strength of Recommendations: Benefits and Harms of Recommendations
</h3>
<div class='FieldValue'>
4
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Evidence Foundations for and Rating Strength of Recommendations: Evidence Summary Supporting Recommendations
</h3>
<div class='FieldValue'>
5
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Evidence Foundations for and Rating Strength of Recommendations: Rating the Strength of Recommendations
</h3>
<div class='FieldValue'>
4
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Specific and Unambiguous Articulation of Recommendations
</h3>
<div class='FieldValue'>
1
</div>

</div>
<div class='field field_picklist-one'>
<h3>
External Review
</h3>
<div class='FieldValue'>
1
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Updating
</h3>
<div class='FieldValue'>
2
</div>

</div>

</div>
<div class='section'>
<h2>Recommendations
</h2>
<div class='field field_text'>
<h3>
Major Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Note from the National Guideline Clearinghouse (NGC)</strong>: Refer to the original guideline document for full dosages, references, and other essential information about the evidence. The recommendation ratings (<strong>Recommended for Practice, Likely To Be Effective, Effectiveness Not Established, Effectiveness Unlikely, Not Recommended for Practice, Expert Opinion</strong>) are defined at the end of the "Major Recommendations" field.</p>
<p>See also the NGC summaries of the related Oncology Nursing Society (ONS) guidelines on cancer-related pain:</p>
<ul style="list-style-type: disc;">
    <li><a href="/summaries/summary/51125" title="Guideline #11279" target="_blank">Chronic and refractory pain: a systematic review of pharmacologic management in oncology</a>. </li>
    <li><a href="/summaries/summary/51126" title="Guideline #11280" target="_blank">Breakthrough cancer pain: a systematic review of pharmacologic management</a>. </li>
    <li><a href="/summaries/summary/51127" title="Guideline #11281" target="_blank">Nonpharmacologic pain interventions: a review of evidence-based practices for reducing chronic cancer pain</a>. </li>
</ul>
<p><strong><span style="text-decoration: underline;">Recommended for Practice</span></strong></p>
<ul style="list-style-type: disc;">
    <li>Epidural analgesia </li>
    <li>Local anesthetic infusion </li>
</ul>
<p><strong><span style="text-decoration: underline;">Likely To Be Effective</span></strong></p>
<p><strong>Pharmacologic Interventions</strong></p>
<ul style="list-style-type: disc;">
    <li>Gabapentin </li>
    <li>Parecoxib </li>
    <li>Intraspinal analgesia </li>
    <li>Oral tramadol </li>
    <li>Naproxen for colony-stimulating factor-related bone pain </li>
    <li>Nefopam </li>
</ul>
<p><strong>Nonpharmacologic Interventions</strong></p>
<ul style="list-style-type: disc;">
    <li>Music and music therapy </li>
    <li>Hypnosis and hypnotherapy </li>
</ul>
<p><strong><span style="text-decoration: underline;">Effectiveness Not Established</span></strong></p>
<p><strong>Pharmacologic Interventions</strong></p>
<ul style="list-style-type: disc;">
    <li>Systemic anesthetics </li>
    <li>Antihistamines </li>
    <li>Anxiolytics </li>
    <li>Dexamethasone with intravenous (IV) chemotherapy </li>
    <li>Intraoperative dexmedetomidine for bladder spasm </li>
    <li>IV fentanyl </li>
    <li>Ketamine </li>
    <li>Morphine mouthwash </li>
    <li>Paravertebral block </li>
    <li>Perioperative drug combinations </li>
    <li>Pregabalin </li>
    <li>Preoperative dexamethasone </li>
    <li>Remifentanil patient-controlled analgesia (PCA) </li>
    <li>Steroid for bone flare pain </li>
    <li>Topical anesthetics </li>
    <li>Transmucosal opioids </li>
</ul>
<p><strong>Nonpharmacologic Interventions</strong></p>
<ul style="list-style-type: disc;">
    <li>Acupressure </li>
    <li>Acupuncture and electroacupuncture </li>
    <li>Foot massage </li>
    <li>Guided imagery and imagery </li>
    <li>Honey </li>
    <li>Massage and aromatherapy massage </li>
    <li>Meditation </li>
    <li>Progressive muscle relaxation and guided imagery </li>
    <li>Reflexology </li>
    <li>Therapeutic touch </li>
    <li>Patient education </li>
</ul>
<p><strong><span style="text-decoration: underline;">Not Recommended for Practice</span></strong></p>
<p>Transdermal fentanyl </p>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong></p>
<p><strong>Recommended for Practice</strong></p>
<p>Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analysis, or systematic reviews, and for which expectation of harms is small compared to the benefits</p>
<p><strong>Likely To Be Effective</strong></p>
<p>Interventions for which effectiveness has been demonstrated from a single rigorously designed conducted controlled trial, consistent supportive evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion </p>
<p><strong>Benefits Balanced With Harm</strong></p>
<p>Interventions for which clinicians and patients should weigh the beneficial and harmful effects according to individual circumstances and priorities</p>
<p><strong>Effectiveness Not Established</strong></p>
<p>Interventions for insufficient or conflicting data or data of inadequate quality currently exist, with no clear indication of harm</p>
<p><strong>Effectiveness Unlikely</strong></p>
<p>Interventions for which lack of effectiveness has been demonstrated by negative evidence from a single rigorously conducted controlled trial, consistent negative evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion</p>
<p><strong>Not Recommended for Practice</strong></p>
<p>Interventions for which lack of effectiveness or harmfulness has been demonstrated by strong evidence from rigorously conducted studies, meta-analyses, or systematic reviews, or interventions where the costs, burden, or harm associated with the intervention exceed anticipated benefit</p>
<p><strong>Expert Opinion</strong></p>
<p>Low-risk interventions that are consistent with sound clinical practice, suggested by an expert in a peer reviewed publication, and for which limited evidence exists (an expert is an individual who has published peer reviewed material in the domain of interest.)</p>
<p>For further information, see the "Decision rules for summative evaluation of a body of evidence" document (see the "Availability of Companion Documents" field). </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Clinical Algorithm(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None provided</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Scope
</h2>
<div class='field field_text'>
<h3>
Disease/Condition(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Cancer-related acute pain</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Guideline Category
</h3>
<div class='FieldValue'>
Management
</div>
<div class='FieldValue'>
Treatment
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Clinical Specialty
</h3>
<div class='FieldValue'>
Nursing
</div>
<div class='FieldValue'>
Oncology
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Intended Users
</h3>
<div class='FieldValue'>
Advanced Practice Nurses
</div>
<div class='FieldValue'>
Nurses
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Objective(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>To critically appraise the strength and quality of the evidence regarding the efficacy of pharmacologic and nonpharmacologic interventions to decrease cancer-related acute pain</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Target Population
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Patients with cancer-related acute pain</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Interventions and Practices Considered
</h3>
<div class='FieldValue'>
<ol style="list-style-type: decimal;" start="1">
    <li>Epidural analgesia </li>
    <li>Local anesthetic infusion </li>
    <li>Gabapentin </li>
    <li>Parecoxib </li>
    <li>Intraspinal analgesia </li>
    <li>Oral tramadol </li>
    <li>Naproxen for colony-stimulating factor-related bone pain </li>
    <li>Nefopam </li>
    <li>Music and music therapy </li>
    <li>Hypnosis and hypnotherapy </li>
</ol>
<p class="Note"><strong>Note: </strong></p>
<ul class="Note" style="list-style-type: disc;">
    <li>The following were considered, but their effectiveness is not established: acupressure, acupuncture/electroacupuncture, systemic anesthetics, antihistamines, anxiolytics, dexamethasone with intravenous (IV) chemotherapy, foot massage, guided imagery and imagery, honey, intraoperative dexmedetomidine for bladder spasm, intravenous fentanyl, ketamine, massage and aromatherapy massage, meditation, morphine mouthwash, paravertebral block, patient education, perioperative drug combinations, pregabalin, preoperative dexamethasone, progressive muscle relaxation and guided imagery, reflexology, remifentanil patient-controlled analgesia (PCA), steroid for bone flare pain, therapeutic touch, topical anesthetics, transmucosal opioids. </li>
    <li>The following was considered but not recommended for practice: transdermal fentanyl. </li>
</ul>
</div>

</div>
<div class='field field_text'>
<h3>
Major Outcomes Considered
</h3>
<div class='FieldValue'>
<ul style="list-style-type: disc;">
    <li>Pain intensity/relief </li>
    <li>Adverse effects </li>
    <li>Quality of life </li>
</ul>
</div>

</div>

</div>
<div class='section'>
<h2>Methodology
</h2>
<div class='field field_picklist-many'>
<h3>
Methods Used to Collect/Select the Evidence
</h3>
<div class='FieldValue'>
Searches of Electronic Databases
</div>

</div>
<div class='field field_text'>
<h3>
Description of Methods Used to Collect/Select the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>To conduct this review, PubMed and CINAHL&reg; were searched from January 1, 2009 to July 31, 2016 to review and evaluate current evidence on pharmacologic and nonpharmacologic interventions for the management of cancer-related acute pain.</p>
<p>The Oncology Nursing Society (ONS) Putting Evidence Into Practice (PEP) program conducted a literature search for pain prior to 2009. Thirty-four articles from the previous search were included in the cancer-related pain guidelines. These articles were subject to the same inclusion and exclusion criteria as the articles for the new search. </p>
<p>Articles from January 2002 to July 2016 are represented in this guideline.</p>
<p><strong><span style="text-decoration: underline;">Pain Topic Search Strategy</span></strong></p>
<p>The following strategy was used across all four pain guidelines (see the "Major Recommendations" field).</p>
<p><strong>Databases Used</strong></p>
<p><em>PubMed</em> </p>
<p>(pain[ti] AND cancer[ti]) OR ((pain[ti] OR pain[majr]) AND neoplasms[majr]) AND (("2009/01/01"[PDAT] : "2016/07/31"[PDAT]) AND "humans"[MeSH Terms] AND English[lang] AND cancer[sb]) </p>
<p><em>CINAHL&reg;</em> </p>
<ul style="list-style-type: disc;">
    <li>(MH "Cancer Pain" OR (TI cancer AND TI pain)) OR ( MM pain AND (cancer OR neoplasms OR oncolog*)) </li>
    <li>Limiters: English language; clinical queries: therapy&ndash;high sensitivity, therapy&ndash;high specificity, therapy&ndash;best balance </li>
</ul>
<p><strong>Inclusion Criteria</strong></p>
<ul style="list-style-type: disc;">
    <li>Full research report, systematic review, guideline, or meta-analysis </li>
    <li>Study must report results of measurement of pain, including acute, chronic, breakthrough, or refractory pain. </li>
    <li>The study examines a pharmacologic or nonpharmacologic intervention aimed at affecting pain. </li>
    <li>Sample must include patients with cancer. </li>
    <li>Include pediatric and/or adult studies </li>
    <li>Studies aimed at treatment of pain (may include other symptoms) rather than treatment of the cancer </li>
    <li>Sample size of at least 40, or 20 per study group </li>
    <li>For complex interventions, the description of the intervention must be sufficient to identify the components of that intervention. </li>
</ul>
<p><strong>Exclusion Criteria</strong></p>
<ul style="list-style-type: disc;">
    <li>Gray literature </li>
    <li>Descriptive study </li>
    <li>Studies involving the use of standard short-acting or sustained or extended-release opioids (Only studies involving new formulations or unusual use of these medications will be included.) </li>
    <li>Studies involving examination of effects of different types of surgical anesthesia </li>
    <li>Studies involving surgical procedures as the primary intervention </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
Number of Source Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This review includes 114 studies of interventions for cancer-related acute pain. </p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Methods Used to Assess the Quality and Strength of the Evidence
</h3>
<div class='FieldValue'>
Expert Consensus (Committee)
</div>
<div class='FieldValue'>
Weighting According to a Rating Scheme (Scheme Given)
</div>

</div>
<div class='field field_text'>
<h3>
Rating Scheme for the Strength of the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Panels of advanced practice nurses, staff nurses, and doctorally-prepared nurse researchers reviewed the literature base in the identified outcome areas. Professional health services librarians assisted in the conduct of the literature searches. Based on their analysis, the panels then formulated a judgment about the body of evidence related to the intervention under consideration. Three major components were considered by the panels in classifying the collective evidence into one of six Weight of Evidence categories (see the "Rating Scheme for the Strength of the Recommendations" field): </p>
<ul style="list-style-type: disc;">
    <li>Quality of the data, with more weight assigned to levels of evidence higher in the PRISM categorization (such as randomized trials and meta-analyses) </li>
    <li>Magnitude of the outcome (e.g., effect size or minimal clinically important difference) </li>
    <li>Concurrence among the evidence (based on the premise that an investigator has less confidence in findings in which the lines of evidence contradict one another) </li>
</ul></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Methods Used to Analyze the Evidence
</h3>
<div class='FieldValue'>
Review of Published Meta-Analyses
</div>
<div class='FieldValue'>
Systematic Review with Evidence Tables
</div>

</div>
<div class='field field_text'>
<h3>
Description of the Methods Used to Analyze the Evidence
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The Oncology Nursing Society (ONS) information resources supervisor thoroughly searched the literature according to the strategy and search terms shown in the "Description of Methods Used to Collect/Select the Evidence" field. Studies that met inclusion criteria were assigned to pairs of pain Putting Evidence Into Practice (PEP) team members, who reviewed and summarized included articles using a standard form. Each article was reviewed by one pain PEP team member and then peer-reviewed by the second pain PEP team member. The form included information about the purpose of the study and a brief description of the intervention, sample size and characteristics, study design, measurement instruments, conclusions, limitations that show risk of bias and threats to validity in design, and implications for nursing practice. </p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Methods Used to Formulate the Recommendations
</h3>
<div class='FieldValue'>
Expert Consensus
</div>

</div>
<div class='field field_text'>
<h3>
Description of Methods Used to Formulate the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The Putting Evidence Into Practice (PEP) program is a multifaceted project that involves the coordination of Oncology Nursing Society (ONS) staff as well as volunteer team contributors. PEP topic teams are comprised of volunteer nurse researchers, advanced practice nurses, and staff nurses who have demonstrated experience and interest in a PEP topic. Topic leaders are nurse scientists or advanced practice nurses with demonstrated expertise in the topic through research and/or publications.</p>
<p>PEP team members applied the ONS PEP classification scheme (see the "Rating Scheme for the Recommendations" field) to individual interventions via Web-based meetings occurring about every six months. PEP team members included nurse scientists, advanced practice nurses, and staff nurses. Classification considers all previous as well as new evidence for each intervention. Conferences are facilitated by ONS research staff and classification of individual interventions is determined by team consensus.</p>
<p>Teams categorize interventions based on the ONS PEP weight-of-evidence classification schema. The schema is intended to be used with existing research-based knowledge on health interventions and is based on previous research. PEP teams consider the entire body of evidence rather than a single study for classification, and more weight is given to studies that rank higher in ONS's priority symptom management project categorization. Team members also consider the magnitude of the outcome and the concurrence of the evidence for an intervention prior to assigning a classification. Interventions are classified by team consensus after application of the schema.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rating Scheme for the Strength of the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong><span style="text-decoration: underline;">Recommended for Practice</span></strong></p>
<p>Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analysis, or systematic reviews, and for which expectation of harms is small compared to the benefits</p>
<p><strong><span style="text-decoration: underline;">Likely To Be Effective</span></strong></p>
<p>Interventions for which effectiveness has been demonstrated from a single rigorously designed conducted controlled trial, consistent supportive evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion </p>
<p><strong><span style="text-decoration: underline;">Benefits Balanced With Harm</span></strong></p>
<p>Interventions for which clinicians and patients should weigh the beneficial and harmful effects according to individual circumstances and priorities</p>
<p><strong><span style="text-decoration: underline;">Effectiveness Not Established</span></strong></p>
<p>Interventions for insufficient or conflicting data or data of inadequate quality currently exist, with no clear indication of harm</p>
<p><strong><span style="text-decoration: underline;">Effectiveness Unlikely</span></strong></p>
<p>Interventions for which lack of effectiveness has been demonstrated by negative evidence from a single rigorously conducted controlled trial, consistent negative evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion</p>
<p><strong><span style="text-decoration: underline;">Not Recommended for Practice</span></strong></p>
<p>Interventions for which lack of effectiveness or harmfulness has been demonstrated by strong evidence from rigorously conducted studies, meta-analyses, or systematic reviews, or interventions where the costs, burden, or harm associated with the intervention exceed anticipated benefit</p>
<p><strong><span style="text-decoration: underline;">Expert Opinion</span></strong></p>
<p>Low-risk interventions that are consistent with sound clinical practice, suggested by an expert in a peer reviewed publication, and for which limited evidence exists (an expert is an individual who has published peer reviewed material in the domain of interest.)</p>
<p>For further information, see the "Decision rules for summative evaluation of a body of evidence" document (see the "Availability of Companion Documents" field). </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Cost Analysis
</h3>
<div class='FieldValue'>
<div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div>
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Method of Guideline Validation
</h3>
<div class='FieldValue'>
External Peer Review
</div>

</div>
<div class='field field_text'>
<h3>
Description of Method of Guideline Validation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The article has been reviewed by independent peer reviewers to ensure that it is objective and free from bias.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Recommendations
</h2>
<div class='field field_text'>
<h3>
Type of Evidence Supporting the Recommendations
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The type of supporting evidence is identified for each recommendation (see the original guideline document).</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Benefits/Harms of Implementing the Guideline Recommendations
</h2>
<div class='field field_text'>
<h3>
Potential Benefits
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong><span style="text-decoration: underline;">Pharmacologic Interventions</span></strong></p>
<ul style="list-style-type: disc;">
    <li>Three randomized, controlled trials (RCTs) conducted among postoperative orthopedic patients and patients who underwent abdominal cancer surgery showed significant reduction in acute postoperative pain with the use of epidural analgesia. Other benefits of epidural analgesia included reduced time to flatus and decreased average length of hospital stay. A double-blind RCT compared thoracic versus lumbar epidural analgesia in post-thoracotomy patients and showed a significant reduction in pain score and consumption of analgesics in the thoracic epidural analgesic group. </li>
    <li>A retrospective cohort study investigated the effect of intraperitoneal bupivacaine on postoperative pain in patients undergoing minimally invasive gynecologic surgeries. That study concluded that instillation of local anesthetic was associated with improved pain control and decreased median narcotic use. </li>
    <li>Along with reduced postoperative pain scores, studies of gabapentin showed additional benefits, including less use of perioperative anesthesia and rescue medication. A double-blind RCT conducted among patients undergoing transurethral resection of the bladder showed significantly lower bladder pain scores and catheter-related discomfort. Preemptive administration of a single dose of gabapentin before total mastectomy significantly reduced the postoperative pain scores and use of analgesic. </li>
    <li>An RCT using a placebo-controlled group showed lower postoperative pain score at all time points and a lower requirement for opioids with intravenous (IV) parecoxib prior to induction of anesthesia and 48 hours following gynecologic surgery. </li>
    <li>A double-blind randomized trial showed preoperative intraspinal morphine doses (0.5 mg and 1 mg) having longer pain control and less analgesic consumption without a difference in adverse effects compared to a dose of 0.2 mg prior to surgery. A double-blind RCT showed that patients receiving intraspinal morphine in addition to patient-controlled anesthesia (PCA) had a lower need for morphine than patients with PCA alone. </li>
    <li>An RCT demonstrated the effectiveness of naproxen (Aleve) in reducing the incidence and severity of pegfilgrastim (Neulasta)-induced bone pain. </li>
    <li>A double-blind RCT evaluated the analgesic efficacy of nefopam (Acupan) on acute and chronic pain after breast surgery. Women were randomized to either the nefopam intervention group or the normal saline placebo-controlled group, in addition to preoperative midazolam and the same anesthetic regimen. Pain scores were significantly lower in the nefopam group at multiple time points during the first 24 hours of surgery. </li>
</ul>
<p><strong><span style="text-decoration: underline;">Nonpharmacologic Interventions</span></strong></p>
<ul style="list-style-type: disc;">
    <li>Several studies involving adult and pediatric patients with cancer in different phases of cancer care suggested that listening to music reduced pain. </li>
    <li>Hypnosis has been tested for various cancer-related symptoms, including pain, anxiety, depression, chemotherapy-induced nausea and vomiting, hot flushes, and fatigue. Overall, current evidence supports the use of hypnosis in ameliorating acute pain in adult and pediatric populations. </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
Potential Harms
</h3>
<div class='FieldValue'>
<div class="content_para"><p>One study noted increased urinary retention with the use of epidural analgesia.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Contraindications
</h2>
<div class='field field_text'>
<h3>
Contraindications
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The U.S. Food and Drug Administration contraindicates the use of fentanyl transdermal patch in the management of postoperative pain because of the risk of serious life-threatening respiratory depression, particularly in opioid-naive patients. </p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Qualifying Statements
</h2>
<div class='field field_text'>
<h3>
Qualifying Statements
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The authors take full responsibility for the content and did not receive honoraria or disclose any relevant financial relationships. The article has been reviewed by independent peer reviewers to ensure that it is objected and free from bias. Mention of specific products and opinions related to those products do not indicate or imply endorsement by the Oncology Nursing Society.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Implementation of the Guideline
</h2>
<div class='field field_text'>
<h3>
Description of Implementation Strategy
</h3>
<div class='FieldValue'>
<div class="content_para"><p>An implementation strategy was not provided.</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Implementation Tools
</h3>
<div class='FieldValue'>
Resources
</div>
<div class='FieldValue'>
Staff Training/Competency Material
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Healthcare Quality Report Categories
</h2>
<div class='field field_picklist-many'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>

</div>
<div class='field field_picklist-many'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>
<div class='FieldValue'>
Patient-centeredness
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information and Availability
</h2>
<div class='field field_citation'>
<h3>
Bibliographic Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Sundaramurthi T, Gallagher N, Sterling B. Cancer-related acute pain: a systematic review of evidence-based interventions for Putting Evidence Into Practice. Clin J Oncol Nurs. 2017 Jun 1;21(3):13-30. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28524911 " target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date Released
</h3>
<div class='FieldValue'>
2017 Jun 1
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Guideline Developer(s)
</h3>
<div class='FieldValue'>
Oncology Nursing Society - Professional Association
</div>

</div>
<div class='field field_text'>
<h3>
Source(s) of Funding
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Oncology Nursing Society</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Committee
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Oncology Nursing Society Putting Evidence Into Practice&reg; (ONS PEP) Expert Panel</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of Group That Authored the Guideline
</h3>
<div class='FieldValue'>
<div class="content_para"><p><em>Authors</em>: Thiruppavai Sundaramurthi, RN, PhD, CCRN, OCN<sup>&reg;</sup>, Natalie Gallagher, RN, MSN, MPH, OCN<sup>&reg;</sup>, and Bethany Sterling, MSN, CRNP, AOCNP<sup>&reg;</sup>, CHPN</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>All volunteers complete the standardized Oncology Nursing Society (ONS) conflict of interest and confidentiality forms.</p>
<p>The authors take full responsibility for this content and did not receive honoraria or disclose any relevant financial relationships.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Aiello-Laws L, Reynolds J, Deizer N, Peterson M, Ameringer S, Bakitas M. Putting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults. Clin J Oncol Nurs. 2009 Dec;13(6):649-55. [55 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Guideline Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Available to subscribers from the <a href="https://cjon.ons.org/cjon/21/3/supplement/cancer-related-acute-pain-systematic-review-evidence-based-interventions" title="Clinical Journal of Oncology Nursing Web site">Clinical Journal of Oncology Nursing Web site</a>. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Availability of Companion Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Brant JM, Eaton LH, Irwin MM. Cancer-related pain: assessment and management with Putting Evidence Into Practice interventions. Clin J Oncol Nurs. 2017 Jun 1;21(3):4-7. Available to subscribers from the <a href="https://cjon.ons.org/cjon/21/3/supplement/cancer-related-pain-assessment-and-management-putting-evidence-practice" title="Clinical Journal of Oncology Nursing Web site">Clinical Journal of Oncology Nursing Web site</a>. </li>
    <li>Acute pain. [internet]. Pittsburgh (PA): Oncology Nursing Society. 2017 Mar 30. Available from the <a href="https://www.ons.org/practice-resources/pep/pain/acute-pain" title="Oncology Nursing Society (ONS) Web site">Oncology Nursing Society (ONS) Web site</a>. </li>
    <li>Mitchell SA, Friese CR. Decision rules for summative evaluation of a body of evidence. [internet]. Pittsburgh (PA): Oncology Nursing Society. Available from the <a href="https://www.ons.org/practice-resources/pep/evaluation-process" title="ONS Web site">ONS Web site</a>. </li>
    <li>Johnson LA. Putting Evidence Into Practice: the process for evidence-based research. Clin J Oncol Nurs. 2014 Dec;18(6 Suppl):2-4. Available from the <a href="https://cjon.ons.org/cjon/18/6/supplement/putting-evidence-practice-process-evidence-based-research" title="Clinical Journal of Oncology Nursing Web site">Clinical Journal of Oncology Nursing Web site</a>. </li>
    <li>Putting Evidence Into Practice (PEP) rating system overview. [internet]. Pittsburgh (PA): Oncology Nursing Society. Available from the <a href="https://www.ons.org/practice-resources/pep" title="ONS Web site">ONS Web site</a>. </li>
    <li>ONS journal activity 2017: cancer-related acute pain: a systematic review of evidence-based interventions for Putting Evidence Into Practice. [internet]. Pittsburgh (PA): Oncology Nursing Society. Available from the <a href="https://www.ons.org/content/ons-journal-activity-2017-cancer-related-acute-pain-systematic-review-evidence-based" title="ONS Web site">ONS Web site</a>. </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
Patient Resources
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None provided</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NGC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NGC summary was completed by ECRI Institute on December 3, 2010. The information was verified by the guideline developer on February 3, 2011. This summary was updated by ECRI Institute on October 28, 2013 following the U.S. Food and Drug Administration advisory on Acetaminophen. The currency of the guideline was reaffirmed by the developer in 2011 and this summary was updated by ECRI Institute on November 8, 2013. This summary was updated by ECRI Institute on September 18, 2015 following the U.S. Food and Drug Administration advisory on non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs). This summary was updated by ECRI Institute on February 5, 2018. The updated information was verified by the guideline developer on February 21, 2018.</p>
<p>This NEATS assessment was completed by ECRI Institute on November 16, 2017. The information was verified by the guideline developer on February 21, 2018.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This summary is based on the original guideline, which is copyrighted by the Oncology Nursing Society (ONS).</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NGC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>
</div>

</div>

</div>
</body></html>